Mar 19, 2021
The topic of today’s podcast is
tenecteplase. This is a thrombolytic drug that is administered
intravenously, for certain patients who present to the hospital
with an acute ischemic stroke. There is mounting evidence
that intravenous tenecteplase is at least as safe and effective as
intravenous alteplase, the current standard of care in ischemic
stroke. Tenecteplase also less expensive and easier to
administer. Our guest today
is Dr. Bruce Campbell, who has played a pivotal role in the
deployment of tenecteplase for stroke. Dr. Campbell was interviewed
by Dr. Michelle Johansen, a vascular neurologist at Johns Hopkins.
Series 2, Episode 5